Etaracizumab (also known as etaratuzumab[citation needed] MEDI-522 trade name Abegrin) is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma prostate cancer ovarian cancer and various other types of cancer. It is manufactured by MedImmune.
This page contains content from the copyrighted Wikipedia article "Etaracizumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.